Wnt/-β-catenin signalling is repressed in poorly differentiated hepatocellular carcinoma cells

被引:0
|
作者
Benhaj, K. [1 ]
Ozturk, N. [1 ]
Yuzugullu, H. [1 ]
Akcali, C. [1 ]
Ozturk, M. [1 ]
机构
[1] Bilkent Univ, Ankara, Turkey
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
PP548
引用
收藏
页码:225 / 225
页数:1
相关论文
共 50 条
  • [1] GSTZ1-1 downregulates Wnt/β-catenin signalling in hepatocellular carcinoma cells
    Lei, Chong
    Wang, Qiujie
    Tang, Ni
    Wang, Kai
    [J]. FEBS OPEN BIO, 2020, 10 (01): : 6 - 17
  • [2] Wnt secretion is not required to sustain Wnt/β-catenin signaling in β-catenin mutant hepatocellular carcinoma cells
    Wang, W.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 61 : S163 - S163
  • [3] CUL4B activates Wnt/β-catenin signalling in hepatocellular carcinoma by repressing Wnt antagonists
    Yuan, Jupeng
    Han, Bo
    Hu, Huili
    Qian, Yanyan
    Liu, Zhaojian
    Wei, Zhao
    Liang, Xiaohong
    Jiang, Baichun
    Shao, Changshun
    Gong, Yaoqin
    [J]. JOURNAL OF PATHOLOGY, 2015, 235 (05): : 784 - 795
  • [4] WNT/β-Catenin Signaling and Hepatocellular Carcinoma
    Wands, Jack R.
    Kim, Miran
    [J]. HEPATOLOGY, 2014, 60 (02) : 452 - 454
  • [5] ATDC promotes the growth and invasion of hepatocellular carcinoma cells by modulating GSK-3β/Wnt/β-catenin signalling
    Li, Weizhi
    Xue, Hui
    Li, Yingchao
    Li, Peijie
    Ma, Fuquan
    Liu, Mengying
    Kong, Shuzhen
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2019, 46 (09) : 845 - 853
  • [6] SAC3D1 activates Wnt/β-catenin signalling in hepatocellular carcinoma
    Wang, Haitao
    Shi, Xiufang
    [J]. MOLECULAR MEDICINE REPORTS, 2022, 26 (04)
  • [7] Clinicopathologic features of poorly differentiated hepatocellular carcinoma
    Oishi, Koichi
    Itamoto, Toshiyuki
    Amano, Hironobu
    Fukuda, Saburo
    Ohdan, Hideki
    Tashiro, Hirotaka
    Shimamoto, Fumio
    Asahara, Toshimasa
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2007, 95 (04) : 311 - 316
  • [8] Poorly differentiated hepatocellular carcinoma with unusual tubular structures
    Yamaguchi, J
    Ojima, H
    Hiraoka, N
    Hasegawa, T
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2005, 58 (12) : 1342 - 1342
  • [9] Clinicopathologic characteristics of WNT/β-catenin deregulated hepatocellular carcinoma
    Bal, Munita
    Verma, Anuj
    Ramadwar, Mukta
    Deodhar, Kedar
    Patil, Prachi
    Goel, Mahesh
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 161 - 161
  • [10] Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment
    Vilchez, Valery
    Turcios, Lilia
    Marti, Francesc
    Gedaly, Roberto
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (02) : 823 - 832